B. Régnier
Impact in
-
- Nosocomial Infections in ICU
Papers in
- Epidemiology 44
- Infective Endocarditis Diagnosis and Management 12
- Pneumocystis jirovecii pneumonia detection and treatment 10
- Surgery 28
- Co-authors
- Michel Wolff (46 shared papers)Jean Carlet (12 shared papers)Lila Bouadma (10 shared papers)Bertrand Gachot (12 shared papers)Jean‐Christophe Lucet (8 shared papers)Benoît Veber (5 shared papers)François Vachon (24 shared papers)Sylvie Chevret (6 shared papers)
- Journals
- Intensive Care Medicine (22 papers)Clinical Infectious Diseases (6 papers)Critical Care Medicine (5 papers)Antimicrobial Agents and Chemotherapy (4 papers)The Lancet (4 papers)
- Partner nations
- FranceUnited StatesVietnam
In The Last Decade
B. Régnier
139 papers receiving 5.9k citations
B. Régnier's Hit Papers
Peers
Comparison fields: 5 of 149
- Critical Care and Intensive Care Medicine 1.1k
- Applied Microbiology and Biotechnology 389
- Molecular Medicine 553
- Infectious Diseases 1.5k
- Epidemiology 2.4k
Countries citing papers authored by B. Régnier
This map shows the geographic impact of B. Régnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Régnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Régnier more than expected).
Fields of papers citing papers by B. Régnier
This network shows the impact of papers produced by B. Régnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Régnier. The network helps show where B. Régnier may publish in the future.
Co-authors
The 25 scholars most cited alongside B. Régnier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 146 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial Hit paper breakdown → | 2010 | 835 |
| 2 | 2009 | 416 | |
| 3 | 2003 | 232 | |
| 4 | 1999 | 229 | |
| 5 | 1998 | 175 | |
| 6 | 1996 | 173 | |
| 7 | 1988 | 156 | |
| 8 | 2003 | 154 | |
| 9 | 1999 | 149 | |
| 10 | Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts. | 1983 | 139 |
| 11 | 1989 | 119 | |
| 12 | 1995 | 116 | |
| 13 | 2005 | 113 | |
| 14 | 2004 | 110 | |
| 15 | 2001 | 108 | |
| 16 | 2010 | 106 | |
| 17 | 2004 | 104 | |
| 18 | 2002 | 104 | |
| 19 | 2003 | 99 | |
| 20 | 2010 | 98 |
About B. Régnier
B. Régnier is a scholar working on Epidemiology, Surgery, Infectious Diseases, Pharmacology and Critical Care and Intensive Care Medicine, having authored 146 papers that have together received 6.3k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Nosocomial Infections in ICU (12 papers), Infective Endocarditis Diagnosis and Management (12 papers), Bacterial Infections and Vaccines (11 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers), Antibiotic Resistance in Bacteria (9 papers), Antibiotic Use and Resistance (9 papers) and Antimicrobial Resistance in Staphylococcus (9 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (1.1k citations), Applied Microbiology and Biotechnology (389 citations), Molecular Medicine (553 citations), Infectious Diseases (1.5k citations) and Epidemiology (2.4k citations). B. Régnier has collaborated with scholars based in France, United States and Vietnam. Frequent co-authors include Michel Wolff, Jean Carlet, Lila Bouadma, Bertrand Gachot, Jean‐Christophe Lucet, Benoît Veber, François Vachon, Sylvie Chevret, Fabrice Bruneel and Frédérique Schortgen. Their work appears in journals such as Intensive Care Medicine, Clinical Infectious Diseases, Critical Care Medicine, Antimicrobial Agents and Chemotherapy and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.